N/A
Completed N=120
Study of Anaesthesia Costs and Recovery Profiles
Anaesthesia
Source: ClinicalTrials.gov NCT02920749 ↗
Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcomePrimary: Drug Consumption — 0.0983; 0.1033; 0.0991; 0.0992 mg — p=<0.05
Summary
The purpose of this study is to compare the perioperative hemodynamic parameters, recovery profiles and cost containment of sevoflurane and propofol based general anesthesia for otorhinolaryngeal surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Drug Consumption |
0.0983; 0.1033; 0.0991; 0.0992; 196.3; 166.4 | <0.05 sig |
| SECONDARY Costs of Anaesthesia |
8.84; 7.86; 8.33; 7.52; 6.49; 23.25 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
- ASA physical status grade I or II who were scheduled for elective otorhinolaryngological surgery.
Exclusion Criteria
- Individuals with a history of bronchial asthma, chronic obstructive pulmonary disease, epilepsy, psychiatric illness, cerebrovascular or congenital neuromuscular disease.
Data sourced from ClinicalTrials.gov (NCT02920749). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.